WHO ICTRP trial
Evaluating lubiprostone for effective in colonoscopic bowel preparation
ChiCTR2400088155 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2400088155 |
|---|---|
| Public title | Evaluating lubiprostone for effective in colonoscopic bowel preparation |
| Scientific title | Evaluating lubiprostone for effective in colonoscopic bowel preparation |
| Primary sponsor | The Affiliated People’s Hospital of Ningbo University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | Bowel Preparation |
| Interventions | 3L PEG + LB group:Use of rupiprostenone before bowel preparation;2L PEG + LB group:Use of rupiprostenone before bowel preparation;4L PEG group:control group 1 ;3L PEG group:control group 12 |
| Registration date | Aug 13, 2024 |
| Target size | 3L PEG + LB group:61;2L PEG + LB group:61;4L PEG group:61;3L PEG group:61 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: